US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist

1.9300
+0.0700+3.76%

Close Mar 11 16:00 ET

1.9300
0.00000.00%

Post 16:00 ET

421.09MMarket Cap-8.77P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akebia Therapeutics Q4 2024 Estimates Date

Currency：USDMar 13, 2025

	Estimate	YoY
Revenue	37.36M	-33.52%
EPS	-0.08	--

Analyst Rating

Buy

Feb 28, 2025

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 37.414M	--
Mar 13, 2025	2024/Q4	-- / 37.356M	--
Nov 7, 2024	2024/Q3	37.428M / 44.505M	--
Aug 8, 2024	2024/Q2	43.648M / 43.653M	--
May 9, 2024	2024/Q1	32.607M / 46.087M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 37.414M--

Mar 13, 20252024/Q4-- / 37.356M--

Nov 7, 20242024/Q337.428M / 44.505M--

Aug 8, 20242024/Q243.648M / 43.653M--

May 9, 20242024/Q132.607M / 46.087M--

Unlock Free Earnings Estimates

Open Account

Akebia Therapeutics Earnings Reports

Akebia Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 07:18 ET

Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 7, 2024 07:08 ET

Akebia Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 07:54 ET

Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 8, 2024 07:09 ET